Genetic variants of the insulin receptor substrate-1 are influencing the therapeutic efficacy of oral antidiabetics.

Seeringer, A; Parmar, S; Fischer, A; Altissimo, B; Zondler, L; Lebedeva, E; Pitterle, K; Roots, I; Kirchheiner, J

Seeringer, A; Parmar, S; Fischer, A; Altissimo, B; Zondler, L; Lebedeva, E; Pitterle, K; Roots, I; Kirchheiner, J.

Affiliation

Seeringer A; Institute of Pharmacology of Natural Products & Clinical Pharmacology, University of Ulm, Ulm, Germany. angela.seeringer@uni-ulm.de

Diabetes Obes Metab ; 12(12): 1106-12, 2010 Dec.

Article in En | MEDLINE | ID: mdl-20977583

Subject(s)

Diabetes Mellitus, Type 2/genetics; Glycated Hemoglobin/genetics; Hypoglycemic Agents/therapeutic use; Insulin Receptor Substrate Proteins/genetics; Polymorphism, Genetic/genetics; Aged; Diabetes Mellitus, Type 2/drug therapy; Female; Humans; Insulin Receptor Substrate Proteins/drug effects; Male

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Glycated Hemoglobin / Diabetes Mellitus, Type 2 / Insulin Receptor Substrate Proteins / Hypoglycemic Agents Limits: Aged / Female / Humans / Male Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2010 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google